Label: YONSA- abiraterone acetate tablet

  • NDC Code(s): 11014-0566-1
  • Packager: Catalent Pharma Solutions, LLC
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Export only

Drug Label Information

Updated November 16, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Package/Label Display Panel Yonsa 125mg tablets

    bottle-label

  • INGREDIENTS AND APPEARANCE
    YONSA 
    abiraterone acetate tablet
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:11014-0566
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ABIRATERONE ACETATE (UNII: EM5OCB9YJ6) (ABIRATERONE - UNII:G819A456D0) ABIRATERONE ACETATE125 mg
    Product Characteristics
    Colorwhite (to off-white) Scoreno score
    ShapeOVALSize12mm
    FlavorImprint Code 125;FP
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:11014-0566-112 in 1 BOX10/03/202211/01/2025
    1120 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Export only10/03/202211/01/2025
    Labeler - Catalent Pharma Solutions, LLC (825745131)
    Establishment
    NameAddressID/FEIBusiness Operations
    Catalent Greenville, Inc.118812386analysis(11014-0566) , pack(11014-0566) , manufacture(11014-0566)
    Establishment
    NameAddressID/FEIBusiness Operations
    Sterling Chemical Malta Ltd360251875api manufacture(11014-0566)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!